483 related articles for article (PubMed ID: 30064504)
1. High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo.
Lenaerts E; Mandro M; Mukendi D; Suykerbuyk P; Dolo H; Wonya'Rossi D; Ngave F; Ensoy-Musoro C; Laudisoit A; Hotterbeekx A; Colebunders R
Infect Dis Poverty; 2018 Aug; 7(1):68. PubMed ID: 30064504
[TBL] [Abstract][Full Text] [Related]
2. Onchocerca volvulus as a risk factor for developing epilepsy in onchocerciasis endemic regions in the Democratic Republic of Congo: a case control study.
Mandro M; Suykerbuyk P; Tepage F; Rossy D; Ngave F; Hasan MN; Hotterbeekx A; Mambandu G; Kashama JM; Laudisoit A; Colebunders R
Infect Dis Poverty; 2018 Oct; 7(1):79. PubMed ID: 30293530
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of epilepsy in an onchocerciasis endemic health zone in the Democratic Republic of the Congo, despite 14 years of community-directed treatment with ivermectin: A mixed-method assessment.
Mukendi D; Tepage F; Akonda I; Siewe JNF; Rotsaert A; Ndibmun CN; Laudisoit A; Couvreur S; Kabutako B; Menon S; Hotterbeekx A; Colebunders R
Int J Infect Dis; 2019 Feb; 79():187-194. PubMed ID: 30711145
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for epilepsy in Bas-Uélé Province, Democratic Republic of the Congo: a case-control study.
Colebunders R; Mandro M; Mokili JL; Mucinya G; Mambandu G; Pfarr K; Reiter-Owona I; Hoerauf A; Tepage F; Levick B; Begon M; Laudisoit A
Int J Infect Dis; 2016 Aug; 49():1-8. PubMed ID: 27210267
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin.
Mmbando BP; Suykerbuyk P; Mnacho M; Kakorozya A; Matuja W; Hendy A; Greter H; Makunde WH; Colebunders R
Infect Dis Poverty; 2018 Jun; 7(1):64. PubMed ID: 29921319
[TBL] [Abstract][Full Text] [Related]
6. Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density.
Siewe Fodjo JN; Mandro M; Mukendi D; Tepage F; Menon S; Nakato S; Nyisi F; Abhafule G; Wonya'rossi D; Anyolito A; Lokonda R; Hotterbeekx A; Colebunders R
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007300. PubMed ID: 31314757
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of epilepsy in onchocerciasis endemic regions in the Democratic Republic of the Congo.
Levick B; Laudisoit A; Tepage F; Ensoy-Musoro C; Mandro M; Bonareri Osoro C; Suykerbuyk P; Kashama JM; Komba M; Tagoto A; Falay D; Begon M; Colebunders R
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005732. PubMed ID: 28708828
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of River Epilepsy in the Orientale Province in the Democratic Republic of the Congo.
Colebunders R; Tepage F; Rood E; Mandro M; Abatih EN; Musinya G; Mambandu G; Kabeya J; Komba M; Levick B; Mokili JL; Laudisoit A
PLoS Negl Trop Dis; 2016 May; 10(5):e0004478. PubMed ID: 27139245
[TBL] [Abstract][Full Text] [Related]
9. Nodding syndrome and epilepsy in onchocerciasis endemic regions: comparing preliminary observations from South Sudan and the Democratic Republic of the Congo with data from Uganda.
Colebunders R; Hendy A; Mokili JL; Wamala JF; Kaducu J; Kur L; Tepage F; Mandro M; Mucinya G; Mambandu G; Komba MY; Lumaliza JL; van Oijen M; Laudisoit A
BMC Res Notes; 2016 Mar; 9():182. PubMed ID: 27005304
[TBL] [Abstract][Full Text] [Related]
10. Onchocerciasis Prevalence among Persons with Epilepsy in an Onchocerciasis Hypo-Endemic Area in the Democratic Republic of Congo: A Cross-Sectional Study.
Hotterbeekx A; Verdonck K; Mukendi D; Lilo-Kalo JR; Lutumba P; Boelaert M; Hardy L; Barbé B; Jacobs J; Bottieau E; Colebunders R
Pathogens; 2021 Mar; 10(4):. PubMed ID: 33805016
[TBL] [Abstract][Full Text] [Related]
11. OV16 Seroprevalence among Persons with Epilepsy in Onchocerciasis Endemic Regions: A Multi-Country Study.
Dusabimana A; Bhwana D; Mandro M; Mmbando BP; Siewe Fodjo JN; Colebunders R
Pathogens; 2020 Oct; 9(10):. PubMed ID: 33081184
[TBL] [Abstract][Full Text] [Related]
12. Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria.
Siewe JNF; Ukaga CN; Nwazor EO; Nwoke MO; Nwokeji MC; Onuoha BC; Nwanjor SO; Okeke J; Osahor K; Chimechefulam L; Ogomaka AI; Amaechi AA; Ezenwa CI; Ezike MN; Ikpeama C; Nwachukwu O; Eriama-Joseph AI; Nwoke BEB; Colebunders R
Infect Dis Poverty; 2019 Jan; 8(1):8. PubMed ID: 30670093
[TBL] [Abstract][Full Text] [Related]
13. Evolution of epilepsy prevalence and incidence in a Tanzanian area endemic for onchocerciasis and the potential impact of community-directed treatment with ivermectin: a cross-sectional study and comparison over 28 years.
Greter H; Mmbando B; Makunde W; Mnacho M; Matuja W; Kakorozya A; Suykerbuyk P; Colebunders R
BMJ Open; 2018 Mar; 8(3):e017188. PubMed ID: 29605818
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin.
Siewe Fodjo JN; Tatah G; Tabah EN; Ngarka L; Nfor LN; Chokote SE; Mengnjo MK; Dema F; Sitouok AT; Nkoro G; Ntone FE; Bissek AZ; Chesnais CB; Boussinesq M; Colebunders R; Njamnshi AK
Infect Dis Poverty; 2018 Dec; 7(1):114. PubMed ID: 30501640
[TBL] [Abstract][Full Text] [Related]
15. Potential Parasitic Causes of Epilepsy in an Onchocerciasis Endemic Area in the Ituri Province, Democratic Republic of Congo.
Vieri MK; Mandro M; Cardellino CS; Orza P; Ronzoni N; Siewe Fodjo JN; Hotterbeekx A; Colebunders R
Pathogens; 2021 Mar; 10(3):. PubMed ID: 33803565
[TBL] [Abstract][Full Text] [Related]
16. Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6-10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening.
Dusabimana A; Siewe Fodjo JN; Ndahura MM; Mmbando BP; Jada SR; Boven A; De Smet E; Ukety T; Njamnshi AK; Laudisoit A; Abrams S; Colebunders R
Pathogens; 2022 Feb; 11(3):. PubMed ID: 35335605
[TBL] [Abstract][Full Text] [Related]
17. Community perceptions of epilepsy and its treatment in an onchocerciasis endemic region in Ituri, Democratic Republic of Congo.
Dolo H; Mandro M; Wonya'Rossi D; Ngave F; Fraeyman J; Siewe JN; Suykerbuyk P; Colebunders R
Infect Dis Poverty; 2018 Dec; 7(1):115. PubMed ID: 30509330
[TBL] [Abstract][Full Text] [Related]
18. The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol.
Abd-Elfarag G; Logora MY; Carter JY; Ojok M; Songok J; Menon S; Wit F; Lako R; Colebunders R
Infect Dis Poverty; 2018 Nov; 7(1):112. PubMed ID: 30424817
[TBL] [Abstract][Full Text] [Related]
19. Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial.
Mandro M; Siewe Fodjo JN; Mukendi D; Dusabimana A; Menon S; Haesendonckx S; Lokonda R; Nakato S; Nyisi F; Abhafule G; Wonya'Rossi D; Jakwong JM; Suykerbuyk P; Meganck J; Hotterbeekx A; Colebunders R
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007966. PubMed ID: 31923177
[TBL] [Abstract][Full Text] [Related]
20. Onchocerca volvulus infection in Tihama region - west of Yemen: Continuing transmission in ivermectin-targeted endemic foci and unveiled endemicity in districts with previously unknown status.
Mahdy MAK; Abdul-Ghani R; Abdulrahman TAA; Al-Eryani SMA; Al-Mekhlafi AM; Alhaidari SAA; Azazy AA
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006329. PubMed ID: 29505580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
